The controversial drive for intervention with ophthalmologic screening for Candida bloodstream infections

• Mark P. Breazzano,
• Luca T. Giurgea,
• H. Russell Day, Jr.,
• Serena Fragiotta,
• Pedro Fernández-Avellaneda,
• Elon H.C. van Dijk,
• Srilaxmi Bearelly,
• John B. Bond, III

Affiliations

Mark P. Breazzano

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York–Presbyterian Hospital, New York, NY, USA; Department of Ophthalmology, New York University School of Medicine, New York University Langone Health, New York, NY, USA; Manhattan Eye, Ear, and Throat Hospital, Northwell Health, New York, NY, USA

Luca T. Giurgea

Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

H. Russell Day, Jr.

Vanderbilt University School of Medicine, Nashville, TN, USA

Serena Fragiotta

Department of Medico–Surgical Sciences and Biotechnologies, U.O.S.D. Ophthalmology, Sapienza University of Rome, Rome, Italy

Pedro Fernández-Avellaneda

Department of Ophthalmology, Basurto University Hospital, Bilbao, Spain

Elon H.C. van Dijk

Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands

Srilaxmi Bearelly

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York–Presbyterian Hospital, New York, NY, USA

John B. Bond, III

Veterans Affairs Tennessee Valley Healthcare System Center, Nashville, TN, USA; Department of Ophthalmology & Visual Sciences, Vanderbilt University School of Medicine, Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, USA; Corresponding author at: Department of Ophthalmology & Visual Sciences, Vanderbilt Eye Institute, Vanderbilt University Medical Center, 2311 Pierce Ave, Nashville, TN 37232, USA.